Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Canada644
Connie Marras28
Canada Sauf Connie Marras" 618
Connie Marras Sauf Canada" 2
Canada Et Connie Marras 26
Canada Ou Connie Marras 646
Corpus10303
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 26.
Ident.Authors (with country if any)Title
000134 Susan H. Fox [Canada] ; Connie MarrasOrthostatic hypotension in Parkinsonism: What is it and how can we treat it?
000205 Melissa J. Armstrong [États-Unis] ; Sarah Duff-Canning ; C. Psych [Canada] ; Matthew Kowgier [Canada] ; Connie Marras [Canada]Independent application of montreal cognitive assessment/mini-mental state examination conversion.
000379 Connie Marras [Canada] ; Alexander I. Tröster ; Jaime Kulisevsky ; Glenn T. StebbinsThe tools of the trade: a state of the art "How to Assess Cognition" in the patient with Parkinson's disease.
000402 Connie Marras [Canada] ; Rachel Saunders-Pullman [États-Unis]The Complexities of Hormonal Influences and Risk of Parkinson’s Disease
000413 Tiago A. Mestre [Canada] ; Alberto J. Espay ; Connie Marras ; Mark H. Eckman ; Pierre Pollak ; Anthony E. LangSubthalamic nucleus-deep brain stimulation for early motor complications in Parkinson's disease-the EARLYSTIM trial: early is not always better.
000441 Naomi P. Visanji [Canada] ; Connie Marras ; Louis W C. Liu ; Lili-Naz Hazrati ; Anthony E. LangReply to: Gray et al.
000670 Naomi P. Visanji [Canada] ; Connie Marras ; Lili-Naz Hazrati ; Louis W C. Liu ; Anthony E. LangAlimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
000918 Connie Marras [Canada] ; Melissa J. Armstrong [Canada] ; Christopher A. Meaney [Canada] ; Susan Fox [Canada] ; Brandon Rothberg [Canada] ; William Reginold [Canada] ; David F. Tang-Wai [Canada] ; David Gill [États-Unis] ; Paul J. Eslinger [États-Unis] ; Cindy Zadikoff [États-Unis] ; Nancy Kennedy [États-Unis] ; Fred J. Marshall [États-Unis] ; Mark Mapstone [États-Unis] ; Kelvin L. Chou [États-Unis] ; Carol Persad [États-Unis] ; Irene Litvan [États-Unis] ; Benjamin T. Mast [États-Unis] ; Adam T. Gerstenecker [États-Unis] ; Sandra Weintraub [États-Unis] ; Sarah Duff-Canning [Canada]Measuring Mild Cognitive Impairment in Patients With Parkinson’s Disease
000B75 William Reginold [Canada] ; Melissa J. Armstrong ; Sarah Duff-Canning ; Anthony Lang ; David Tang-Wai ; Susan Fox ; Brandon Rothberg ; Cindy Zadikoff ; Nancy Kennedy ; David Gill ; Paul Eslinger ; Mark Mapstone ; Kelvin Chou ; Carol Persad ; Irene Litvan ; Benjamin Mast ; Connie MarrasThe pill questionnaire in a nondemented Parkinson's disease population.
000F50 William Reginold [Canada] ; Melissa J. Armstrong [Canada] ; Sarah Duff-Canning [Canada] ; Anthony Lang [Canada] ; David Tang-Wai [Canada] ; Susan Fox [Canada] ; Brandon Rothberg [Canada] ; Cindy Zadikoff [États-Unis] ; Nancy Kennedy [États-Unis] ; David Gill [États-Unis] ; Paul Eslinger [États-Unis] ; Mark Mapstone [États-Unis] ; Kelvin Chou [États-Unis] ; Carol Persad [États-Unis] ; Irene Litvan [États-Unis] ; Benjamin Mast [États-Unis] ; Connie Marras [Canada]The Pill Questionnaire in a Nondemented Parkinson's Disease Population
001110 Samuel M. Goldman [États-Unis] ; Freya Kamel [États-Unis] ; G. Webster Ross [États-Unis] ; Grace S. Bhudhikanok [États-Unis] ; Jane A. Hoppin [États-Unis] ; Monica Korell [États-Unis] ; Connie Marras [Canada] ; Cheryl Meng [États-Unis] ; David M. Umbach [États-Unis] ; Meike Kasten [Allemagne] ; Anabel R. Chade [Argentine] ; Kathleen Comyns [États-Unis] ; Marie B. Richards [États-Unis] ; Dale P. Sandler [États-Unis] ; Aaron Blair [États-Unis] ; J. William Langston [États-Unis] ; Caroline M. Tanner [États-Unis]Genetic Modification of the Association of Paraquat and Parkinson's Disease
001334 Christine Klein [Canada, Allemagne] ; Rosalind Chuang [Canada] ; Connie Marras [Canada] ; Anthony E. Lang [Canada]The curious case of phenocopies in families with genetic Parkinson's disease
001419 Alberto J. Espay [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Connie Marras [Canada] ; Rob Fowler [Canada] ; Mark H. Eckman [États-Unis]Reply: Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson's disease: Need for long‐term clinical trials
001459 Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Ken Marek [États-Unis] ; Paula Rochon [Canada] ; Gary Naglie [Canada] ; Caroline M. Tanner [États-Unis] ; Alice Rudolph [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada]Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts
001D24 Alberto J. Espay [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Connie Marras [Canada] ; Rob Fowler [Canada] ; Mark H. Eckman [États-Unis]Early versus delayed bilateral subthalamic deep brain stimulation for parkinson's disease: A decision analysis
002483 Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Shirley W. Eberly [États-Unis] ; David Oakes [États-Unis] ; Stanley Fahn [États-Unis] ; Steven R. Schwid [États-Unis] ; Christopher Hyson [Canada] ; Ira Shoulson [États-Unis]A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts
002603 Renato P. Munhoz [Brésil] ; Yosuke Wakutani [Canada] ; Connie Marras [Canada] ; Helio A. Teive [Brésil] ; Salmo Raskin [Brésil] ; Lineu C. Werneck [Brésil] ; Danielle Moreno [Canada] ; Christine Sato [Canada] ; Anthony E. Lang [Canada] ; Ekaterina Rogaeva [Canada]The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease: Phenotype in monozygotic twins
002679 Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Paula A. Rochon [Canada] ; Caroline M. Tanner [États-Unis] ; Gary Naglie [Canada] ; Anthony E. Lang [Canada]Predictors of deterioration in health‐related quality of life in Parkinson's disease: Results from the DATATOP trial
002A35 Cindy Zadikoff [États-Unis, Canada] ; Susan H. Fox [Canada] ; David F. Tang-Wai [Canada] ; Teri Thomsen [Canada] ; Rob M. A. De Bie [Canada, Pays-Bas] ; Pettarusup Wadia [Canada] ; Janis Miyasaki [Canada] ; Sarah Duff-Canning [Canada] ; Anthony E. Lang [Canada] ; Connie Marras [Canada]A comparison of the mini mental state exam to the montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease
002B11 Asha Kishore [Canada] ; Alberto J. Espay [Canada] ; Connie Marras [Canada] ; Thamer Al-Khairalla [Canada] ; Tamara Arenovich [Canada] ; Abena Asante [Canada] ; Janis Miyasaki [Canada] ; Anthony E. Lang [Canada]Unilateral versus bilateral tasks in early asymmetric Parkinson's disease: Differential effects on bradykinesia
002D88 Ronald B. Postuma [Canada] ; Christina Wolfson [Canada] ; Ali Rajput [Canada] ; A. Jon Stoessl [Canada] ; W. R. Wayne Martin [Canada] ; Oksana Suchowersky [Canada] ; Sylvain Chouinard [Canada] ; Michel Panisset [Canada] ; Mandar S. Jog [Royaume-Uni] ; David A. Grimes [Canada] ; Connie Marras [Canada] ; Anthony E. Lang [Canada]Is there seasonal variation in risk of Parkinson's disease?
003017 Connie Marras [Canada] ; Alexander Kopp [Canada] ; Feng Qiu [Canada] ; Anthony E. Lang [Canada] ; Kathy Sykora [Canada] ; Kenneth I. Shulman [Canada] ; Paula A. Rochon [Canada]Antipsychotic use in older adults with Parkinson's disease
003B68 Connie Marras [Canada]Re: Cabergoline versus levodopa monotherapy: A decision analysis
003B73 Connie Marras [Canada] ; Anthony Lang [Canada] ; Murray Krahn [Canada] ; George Tomlinson [Canada] ; Gary Naglie [Canada]Quality of life in early Parkinson's disease: Impact of dyskinesias and motor fluctuations
004886 Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Lee Cyn Ang [Canada] ; Jcm Zijlmans [Royaume-Uni] ; G. K. Wenning [Autriche]69‐Year‐old man with gait disturbance and parkinsonism
004B20 Connie Marras [Canada] ; Annette V. Nieves [Canada]Book reviews

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024